Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
Clinical trial NCT06219239 · RECRUITING
Trial details
- NCT number
- NCT06219239
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2025-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.